[1]徐楚潇 何为 肖若陶 刘承 王国良 田晓军 马潞林**.双侧散发性肾癌37例手术策略分析[J].中国微创外科杂志,2021,01(4):340-345.
　Xu Chuxiao,He Wei,Xiao Ruotao,et al.Surgical Strategies Analysis of Bilateral Sporadic Renal Cell Carcinoma：Report of 37 Cases[J].Chinese Journal of Minimally Invasive Surgery,2021,01(4):340-345.
点击复制

双侧散发性肾癌37例手术策略分析()
分享到：

《中国微创外科杂志》[ISSN:1009-6604/CN:11-4526/R]

卷:
01
期数:
2021年4期
页码:
340-345
栏目:
临床研究
出版日期:
2021-04-25

文章信息/Info

Title:
Surgical Strategies Analysis of Bilateral Sporadic Renal Cell Carcinoma：Report of 37 Cases
作者:
徐楚潇 何为 肖若陶 刘承 王国良 田晓军 马潞林**
（北京大学第三医院泌尿外科，北京100191）
Author(s):
Xu Chuxiao;  He Wei;  Xiao Ruotao;  et al.
Department of Urology, Peking University Third Hospital, Beijing 100191, China
关键词:
双侧散发性肾癌; 囊性肾癌; 后腹腔镜; 保留肾单位手术; 根治性肾切除
Keywords:
Bilateral sporadic renal cell carcinoma; Cystic renal cell carcinoma; Retroperitoneal laparoscopy; Nephronsparing surgery; Radical nephrectomy
文献标志码:
A
摘要:
目的探讨双侧散发性肾癌（bilateral sporadic renal cell carcinoma, BSRCC）的手术治疗策略。方法回顾分析我院2000年6月~2020年6月37例BSRCC的临床资料。全麻下建立腹膜后操作空间，行后腹腔镜保留肾单位手术（nephronsparing surgery, NSS）或根治性肾切除术（radical nephrectomy，RN）。对肿瘤体积大、与周围组织粘连严重、复杂囊性肿瘤，行后腹腔镜探查、中转开放手术或直接行开放手术切除。结果37例均成功行双侧手术治疗，其中22例行双侧NSS，15例行一侧NSS、对侧RN。1例行同期NSS+RN后出现Clavein Ⅳa级肾功能不全，行血液透析治疗，其余36例术后恢复良好，未发生并发症。14枚囊性肿瘤中，除2枚行腹腔镜探查、中转开放NSS外，其余12枚成功行完全后腹腔镜下NSS。82枚肿瘤中，肾透明细胞癌66枚，肾嗜酸/嫌色细胞混合性肿瘤7枚，低度恶性潜能多房囊性肾肿瘤 3枚，乳头状肾细胞癌（renal cell carcinoma，RCC）Ⅰ型2枚，RCC未分类型2枚，肾嫌色细胞癌1枚，管状囊性RCC 1枚。术后病理核分级：G1 7例，G2 18例，G3 10例，G4 2例。35例随访4~194个月，中位时间30个月。30例存活，5例死亡，10例术后发生远处转移。2年总生存率91.3%，2年无进展生存率82.6%。结论BSRCC积极行双侧手术治疗效果良好，双侧腹腔镜NSS是较为理想的选择。对囊性RCC行腹腔镜NSS难度较大，常需手术经验丰富的医师进行操作。BSRCC具有多灶性、易复发的特点，术后应严密随访。
Abstract:
ObjectiveTo explore the surgical strategies of bilateral sporadic renal cell carcinoma (BSRCC).MethodsThis retrospective study analyzed clinical data of 37 patients with BSRCC from June 2000 to June 2020 in our hospital. Retroperitoneal space was established under general anesthesia for retroperitoneal laparoscopic nephron sparing surgery (NSS) or radical nephrectomy (RN). For cases with tumors of large volume, severe adhesion to adjacent tissues or complex cystic features, laparoscopic exploration converting to open resection or direct open resection were performed.ResultsAll the 37 patients underwent bilateral surgical treatments. There were 22 cases of bilateral NSS and 15 cases of NSS plus contralateral RN. One patient suffered Clavein Ⅳa renal dysfunction and he was managed with hemodialysis. The remaining 36 patients recovered uneventfully. Among the 14 cystic renal tumors, 12 were managed with totally retroperitoneat laparoscopic NSS while 2 received laparoscopic exploration and open resection. Among the 82 tumors, 66 were clear cell carcinoma of the kidney, 7 were renal hybrid oncocytic/chromophobe tumors, 3 were multilocular cystic renal neoplasms of low malignant potential, 2 were papillary renal cell carcinoma type Ⅰ, 2 were unclassified renal cell carcinoma, 1 was chromophobe renal cell carcinoma, and 1 was tubulocystic renal cell carcinoma. In terms of postoperative nuclear grades, 7 patients were grade 1 (G1), 18 patients were grade 2 (G2), 10 patients were grade 3 (G3), and 2 patients were grade 4 (G4).A total of 35 cases were followed up for 4-194 months, with a median of 30 months. There were 30 cases survived, 5 cases died and 10 cases of distant metastasis. The 2year cumulative survival rate was 91.3%, and the 2year cumulative progression free survival rate was 82.6%.ConclusionsBilateral laparoscopic NSS is an ideal choice for BSRCC. Laparoscopic NSS for cystic RCC is difficult, and it often needs experienced surgeons. BSRCC is multifocal and easy to recur, so it should be followed up closely.

参考文献/References:

[1]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin,2019,69(1):7-34.
[2]Lowrance WT, Yee DS, Maschino AC, et al. Developments in the surgical management of sporadic synchronous bilateral renal tumours. BJU Int,2010,105(8):1093-1097.
[3]Qi N, Li T, Ning X, et al. Clinicopathologic features and prognosis of sporadic bilateral renal cell carcinoma: A series of 148 cases. Clin Genitourin Cancer,2017,15(5):618-624.
[4]Klatte T, Wunderlich H, Patard JJ, et al. Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience. BJU Int,2007,100(1):21-25.
[5]Klatte T, Patard JJ, Wunderlich H, et al. Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primaryfree interval. J Urol,2007,177(6):2081-2087.
[6]Zhao PT, Richstone L, Kavoussi LR. Laparoscopic partial nephrectomy. Int J Surg,2016,36:548-553.
[7]王林辉,时佳子.肾癌肾部分切除术的指征应该怎么把握.中华泌尿外科杂志,2018,39(6):403-406.
[8]Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications,techniques and outcomes.J Urol,2001,166(1):6-18.
[9]Allan JD, Tolley DA, Kaouk JH, et al. Laparoscopic radical nephrectomy. Eur Urol,2001,40(1):17-23.
[10]严俊,余辉,应敏刚,等.腹腔镜下与开放性根治性肾切除术的前瞻性随机对照研究.中华泌尿外科杂志,2010,31(7):449-451.
[11]黄兴,石洪波,王蕾,等.后腹腔镜根治性肾切除术与开放手术治疗局限性肾癌的疗效比较.现代泌尿生殖肿瘤杂志,2010,2(1):16-18.
[12]陈伟,陈勇辉,张进,等.腹腔镜和开放肾部分切除术治疗T1b期肾癌的近期疗效比较.临床泌尿外科杂志,2017,32(5):339-343.
[13]姚鲲,周利群,李学松,等.腹腔镜与开放性肾部分切除术治疗小肾癌的安全性与疗效分析.中华外科杂志,2010,48(5):372-374.
[14]Patel AR, Lee BH, Campbell SC, et al. Bilateral synchronous sporadic renal tumors: pathologic concordance and clinical implications. Urology,2011,78(5):1095-1099.
[15]Rothman J, Crispen PL, Wong YN, et al. Pathologic concordance of sporadic synchronous bilateral renal masses. Urology,2008,72(1):138-142.
[16]Singer EA, Vourganti S, Lin KY, et al. Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup. J Urol,2012,188(6):2084-2088.
[17]Wang B, Gong H, Zhang X, et al. Bilateral synchronous sporadic renal cell carcinoma: Retroperitoneoscopic strategies and intermediate outcomes of 60 patients. PLoS One,2016,11(5): e0154578.
[18]Volpe A, Amparore D, Mottrie A. Treatment outcomes of partial nephrectomy for T1b tumours. Curr Opin Urol,2013,23(5):403-410.
[19]Maddox M, Mandava S, Liu J, et al. Robotic partial nephrectomy for clinical stage T1b tumors: intermediate oncologic and functional outcomes. Clin Genitourin Cancer,2015,13(1):94-99.
[20]Gershman B, Thompson RH, Boorjian SA, et al. Radical versus partial nephrectomy for cT1 renal cell carcinoma. Eur Urol,2018,74(6):825-832.
[21]Derweesh IH, Ryan ST, Hamilton ZA. Partial nephrectomy for T1b and T2 renal masses: A subtle paradigm shift and a new synthesis. Cancer,2018,124(19):3798-3801.
[22]Miyagawa T, Shimazui T, Hinotsu S, et al. Does tumor size or microvascular invasion affect prognosis in patients with renal cell carcinoma? Jpn J Clin Oncol,2007,37(3):197-200.
[23]Williamson SR, Taneja K, Cheng L. Renal cell carcinoma staging: pitfalls, challenges, and updates. Histopathology,2019,74(1):18-30.
[24]Mir MC, Derweesh I, Porpiglia F, et al. Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: A systematic review and metaanalysis of comparative studies. Eur Urol,2017,71(4):606-617.
[25]Yasuda Y, Yuasa T, Yamamoto S, et al. Evaluation of the RENAL nephrometry scoring system in adopting nephronsparing surgery for cT1 renal cancer. Urol Int,2013,90(2):179-183.
[26]Shin SJ, Ko KJ, Kim TS, et al. Trends in the use of nephronsparing surgery over 7 years: an analysis using the R.E.N.A.L. nephrometry scoring system. PLoS One,2015,10(11):e0141709.
[27]Ljungberg B, Albiges L, AbuGhanem Y, et al. European Association of Urology guidelines on renal cell carcinoma: The 2019 update. Eur Urol,2019,75(5):799-810.
[28]Motzer RJ, Jonasch E, Michaelson MD, et al. NCCN Guidelines Insights: Kidney Cancer, Version 2.2020. J Natl Compr Canc Netw,2019,17(11):1278-1285.
[29]Becker F, Siemer S, Tzavaras A, et al. Longterm survival in bilateral renal cell carcinoma: a retrospective singleinstitutional analysis of 101 patients after surgical treatment. Urology,2008, 72(2):349-353.
[30]Xu B, Mi Y, Zhou LQ, et al. Laparoscopic partial nephrectomy for multilocular cystic renal cell carcinoma: a potential gold standard treatment with excellent perioperative outcomes. World J Surg Oncol,2014,12:111.
[31]Xu B, Wang JJ, Mi Y, et al. Laparoscopic versus open partial nephrectomy for multilocular cystic renal cell carcinoma: a direct comparison based on singlecenter experience. Urol Int,2015,94(1):83-87.
[32]Akca O, Zargar H, Autorino R, et al. Robotic partial nephrectomy for cystic renal masses: a comparative analysis of a matchedpaired cohort. Urology,2014,84(1):93-98.
[33]Boorjian SA, Crispen PL, Lohse CM, et al. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. Eur Urol,2008,54(4):855-863.
[34]Blute ML, Itano NB, Cheville JC, et al. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma. J Urol,2003,169(4):1276-1281.
[35]巩会杰,王保军,张旭,等.散发性双肾癌的临床病理特征及手术疗效分析.中华泌尿外科杂志,2015,36(4):249-253.

备注/Memo

备注/Memo:
基金项目: 国家自然科学基金面上项目（81972381） **通讯作者, Email:malulin@medmail.com.cn
更新日期/Last Update: 2021-06-30